Highlights Eurofins Scientific SE

Equities

Market Closed - Euronext Paris Other stock markets 11:35:26 2024-05-30 am EDT			5-day change	1st Jan Change
55.58 ^EUR	+0.36%		-3.71%	-5.76%

May. 13	Eurofins Scientific to Expand US Battery Materials Testing Capabilities	MT
May. 13	Eurofins Scientific expands capacity in the USA	CF

Eurofins Scientific to Expand US Battery Materials Testing Capabilities	May. 13	MT
Eurofins Scientific expands capacity in the USA	May. 13	CF
Corella Resources Confirms High Purity Alumina Production	May. 08	MT
CAC40: France's rating maintained = non-event	Apr. 29	CF
CAC40: starts the week slightly up, crosses the 8100 mark	Apr. 29	CF
CAC40: interest rates soar, pulling back below 8100 pts	Apr. 24	CF
EUROFINS SCIENTIFIC : Q1 sees a lacklustre start to the year; 2024 outlook confirmed	Apr. 24
CAC40: reverses course under pressure from rates at their zenith	Apr. 24	CF
CAC40: rise to 8.150, but interest-rate tensions hinder progress	Apr. 24	CF
Eurofins Scientific SE's Equity Buyback announced on October 3, 2022, has expired.	Apr. 23	CI
CAC40: pullback reduced, WStreet +0.7%, Brent at $91, Gold at $233	Apr. 05	CF
CAC40: easily preserves 8,000Pts, NFP has no impact	Apr. 05	CF
CAC40: ends the day balanced after a salvo of statistics	Apr. 04	CF
CAC40: frozen at 8,155, W-Street well disposed, gold at its zenith	Apr. 04	CF
EUROFINS SCIENTIFIC : Berenberg raises its price target	Apr. 04	CF
CAC40: up slightly after PMI figures	Apr. 04	CF
Eurofins Scientific to Purchase US-based Ascend Clinical	Apr. 03	MT
Eurofins completes acquisition of Ascend Clinical	Apr. 03	CF
Eurofins Scientific SE acquired Ascend Clinical, LLC.	Apr. 02	CI
CAC40: ends with a balanced performance, helped by the banking sector	Mar. 28	CF

No results for this search

EUROFINS SCIENTIFIC : Q1 sees a lacklustre start to the year; 2024 outlook confirmed

April 24, 2024 at 11:50 am EDT